Conmed (CNMD) Tops Q1 EPS by 9c; Raises Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. META
6. BA
7. SPY
8. INTC
9. JBLU
10. HOOD

Go back to Conmed (CNMD) Tops Q1 EPS by 9c; Raises Outlook

CONMED (CNMD) PT Raised to $73 at Needham & Company

April 26, 2018 6:54 AM EDT

Needham & Company raised its price target on CONMED (NASDAQ: CNMD) to $73.00 (from $71.00) while maintaining a Buy rating.

Analyst Mike Matson commented, "CNMD's 1Q18 revenue and EPS beat consensus and management raised its 2018 revenue and EPS guidance. Revenue growth slowed somewhat to 6.8% CC... More